This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
respiratory syndrome | 366 |
influenza virus | 318 |
virus infection | 286 |
acute respiratory | 280 |
amino acid | 267 |
infectious bronchitis | 241 |
time pcr | 216 |
cell lines | 205 |
infected cells | 204 |
syndrome coronavirus | 202 |
bronchitis virus | 189 |
respiratory tract | 187 |
severe acute | 186 |
cell culture | 174 |
additional file | 171 |
viral rna | 168 |
herpes simplex | 168 |
respiratory syncytial | 167 |
dengue virus | 164 |
middle east | 163 |
syncytial virus | 161 |
simplex virus | 156 |
avian influenza | 152 |
respiratory viruses | 147 |
east respiratory | 146 |
influenza viruses | 140 |
virus replication | 135 |
cord uid | 133 |
doc id | 133 |
virus type | 130 |
porcine epidemic | 129 |
pcr assay | 128 |
amino acids | 127 |
present study | 126 |
control group | 123 |
immune response | 119 |
epidemic diarrhea | 117 |
competing interests | 114 |
time rt | 114 |
human coronavirus | 113 |
viral replication | 113 |
chain reaction | 113 |
gene expression | 113 |
nucleic acid | 112 |
epithelial cells | 112 |
phylogenetic analysis | 111 |
polymerase chain | 110 |
reverse transcription | 110 |
western blot | 108 |
authors declare | 106 |
diarrhea virus | 104 |
vero cells | 96 |
type i | 91 |
performed using | 91 |
canine parvovirus | 90 |
described previously | 87 |
immune responses | 86 |
previously described | 86 |
cell surface | 85 |
viral infections | 85 |
human metapneumovirus | 83 |
viral infection | 83 |
serum samples | 82 |
codon usage | 81 |
antiviral activity | 81 |
rna viruses | 80 |
cell line | 78 |
transfected cells | 77 |
viral load | 77 |
disease virus | 77 |
results showed | 76 |
hcv rna | 76 |
final manuscript | 76 |
respiratory infections | 74 |
avian infectious | 73 |
viral particles | 72 |
tract infections | 70 |
negative control | 69 |
authors read | 69 |
human respiratory | 69 |
reference genes | 69 |
room temperature | 68 |
virus entry | 68 |
reverse transcriptase | 67 |
lower respiratory | 67 |
virus particles | 66 |
virus infections | 64 |
pcr products | 63 |
monoclonal antibody | 63 |
viral particle | 63 |
sequence analysis | 62 |
closely related | 62 |
viral proteins | 61 |
immunodeficiency virus | 61 |
open reading | 61 |
spike protein | 61 |
cell cultures | 61 |
structural proteins | 60 |
respiratory disease | 60 |
three times | 60 |
pcr assays | 60 |
orf protein | 59 |
previous studies | 59 |
stool samples | 59 |
rna pol | 58 |
highly conserved | 57 |
infectious diseases | 57 |
fever virus | 57 |
mammalian cells | 56 |
positive samples | 56 |
well plates | 56 |
bovine serum | 56 |
innate immune | 56 |
rna interference | 56 |
united states | 56 |
novel coronavirus | 55 |
public health | 55 |
virus titers | 54 |
transmissible gastroenteritis | 54 |
syndrome virus | 54 |
swine fever | 53 |
nucleocapsid protein | 53 |
respiratory illness | 53 |
bacterial microbiome | 53 |
sequence alignment | 53 |
monoclonal antibodies | 53 |
respiratory virus | 52 |
porcine reproductive | 51 |
post infection | 51 |
class iii | 51 |
goat anti | 50 |
statistically significant | 50 |
vaccinia virus | 50 |
clinical samples | 50 |
hong kong | 50 |
hsv infection | 50 |
fusion protein | 50 |
clinical signs | 49 |
cov infection | 49 |
orf gene | 48 |
nucleic acids | 48 |
kidney cells | 47 |
dna polymerase | 47 |
cells infected | 47 |
leukemia virus | 47 |
molecular epidemiology | 46 |
spike gene | 46 |
dpb dpc | 46 |
neutralizing antibodies | 46 |
encephalitis virus | 46 |
virus isolation | 46 |
african swine | 46 |
rna virus | 46 |
applied biosystems | 45 |
genetic diversity | 45 |
days post | 45 |
cell entry | 45 |
viral dna | 45 |
samples collected | 44 |
er stress | 44 |
human bocavirus | 44 |
virus glycoprotein | 44 |
fecal samples | 44 |
stranded rna | 43 |
ark dpi | 43 |
flow cytometry | 43 |
human immunodeficiency | 43 |
viral genome | 43 |
sars coronavirus | 42 |
rna polymerase | 42 |
borna disease | 42 |
total rna | 42 |
human cytomegalovirus | 42 |
host cell | 42 |
hemorrhagic fever | 42 |
mg ml | 42 |
infectious virus | 42 |
huh cells | 42 |
respiratory infection | 42 |
class ii | 41 |
adenovirus type | 41 |
nk cells | 41 |
ns protein | 41 |
immune system | 41 |
nucleotide sequence | 41 |
plaque assay | 41 |
significantly higher | 40 |
coronavirus infection | 40 |
time points | 40 |
class i | 40 |
complete genome | 40 |
virus strains | 40 |
biomed central | 40 |
next manuscript | 40 |
endoplasmic reticulum | 40 |
protein expression | 40 |
highly pathogenic | 39 |
cell epitopes | 39 |
linked immunosorbent | 39 |
multiple sequence | 39 |
secondary antibody | 39 |
saudi arabia | 39 |
maximum likelihood | 39 |
human coronaviruses | 38 |
combination sirnas | 38 |
supplementary material | 38 |
genome sequence | 38 |
mouse igg | 38 |
vaccine strains | 38 |
mild flu | 38 |
infected mice | 38 |
human adenovirus | 38 |
ibv strains | 38 |
host cells | 38 |
peripheral blood | 38 |
novel human | 37 |
dendritic cells | 37 |
immunosorbent assay | 37 |
iii vfp | 37 |
buffered saline | 37 |
tissue culture | 37 |
newcastle disease | 37 |
dpc ie | 37 |
viral loads | 37 |
molecular characterization | 37 |
glycosylation sites | 37 |
specific primers | 37 |
acid sequences | 37 |
acid extraction | 37 |
animal models | 37 |
dhf cases | 37 |
endothelial cells | 36 |
acid sequence | 36 |
respiratory viral | 36 |
drug resistance | 36 |
feline leukemia | 36 |
mk cells | 36 |
colloidal gold | 36 |
mouse anti | 36 |
important role | 36 |
reading frame | 36 |
cell fusion | 36 |
cotton rats | 36 |
phylogenetic analyses | 36 |
simultaneous detection | 36 |
internal control | 36 |
nested pcr | 36 |
nitric oxide | 36 |
hospitalized children | 35 |
positive control | 35 |
domestic cats | 35 |
standard curve | 35 |
human influenza | 35 |
hpv types | 35 |
current study | 35 |
mini kit | 35 |
host range | 35 |
host factors | 35 |
viral entry | 35 |
synonymous codon | 35 |
nasal swabs | 35 |
nucleotide sequences | 34 |
virus strain | 34 |
blot analysis | 34 |
envelope glycoprotein | 34 |
hcvcc infection | 34 |
rna replication | 34 |
viral fusion | 34 |
reading frames | 34 |
virus culture | 34 |
electron microscopy | 34 |
chicken eggs | 34 |
real time | 34 |
reverse genetics | 34 |
south kivu | 34 |
luciferase activity | 34 |
quantitative real | 34 |
western blotting | 33 |
time reverse | 33 |
genbank accession | 33 |
gastroenteritis virus | 33 |
persistent infection | 33 |
i interferon | 33 |
promoter activity | 33 |
viral envelope | 33 |
fusion proteins | 33 |
positive selection | 33 |
japanese encephalitis | 33 |
parvovirus type | 33 |
envelope protein | 33 |
cd cd | 33 |
west nile | 33 |
coronavirus nl | 32 |
structural protein | 32 |
plasma membrane | 32 |
molecular methods | 32 |
pedv strain | 32 |
phylogenetic tree | 32 |
previously reported | 32 |
receptor binding | 32 |
ibv strain | 32 |
fetal bovine | 32 |
santa cruz | 32 |
vp gene | 31 |
analysis using | 31 |
clinical symptoms | 31 |
nervous system | 31 |
hcv infection | 31 |
lassa virus | 31 |
particle inoculation | 31 |
full length | 31 |
two different | 31 |
immunochromatographic strip | 31 |
membrane protein | 31 |
swine influenza | 31 |
allantoic fluid | 30 |
viral protein | 30 |
viral pathogens | 30 |
necrosis factor | 30 |
bat species | 30 |
tcid ml | 30 |
human papillomavirus | 30 |
membrane fusion | 30 |
expression vector | 30 |
like particles | 30 |
copies ml | 30 |
accession numbers | 30 |
expression levels | 30 |
pcr using | 30 |
developing countries | 29 |
dengue fever | 29 |
viruses isolated | 29 |
economic losses | 29 |
cells expressing | 29 |
vaccine strain | 29 |
world health | 29 |
previous study | 29 |
indirect elisa | 29 |
throat swabs | 29 |
statistical analysis | 29 |
nile virus | 29 |
st cells | 29 |
immune cells | 29 |
blood samples | 29 |
analyzed using | 29 |
phylogenetic trees | 29 |
np swabs | 29 |
cells transfected | 29 |
calf serum | 29 |
pcr product | 28 |
bovine coronavirus | 28 |
virus detection | 28 |
young children | 28 |
agarose gel | 28 |
dependent rna | 28 |
dengue hemorrhagic | 28 |
cell monolayers | 28 |
envelope glycoproteins | 28 |
hbov promoter | 28 |
target cells | 28 |
like illness | 28 |
reporter gene | 28 |
gel electrophoresis | 28 |
tract infection | 28 |
infected cell | 27 |
sialic acid | 27 |
survival rate | 27 |
natural killer | 27 |
conjugated goat | 27 |
also showed | 27 |
quantitative rt | 27 |
different concentrations | 27 |
polyclonal antibody | 27 |
south korea | 27 |
published maps | 27 |
rapid detection | 27 |
jurisdictional claims | 27 |
institutional affiliations | 27 |
nature remains | 27 |
adaptive immune | 27 |
small interfering | 27 |
multiplex real | 27 |
specific sirna | 27 |
remains neutral | 27 |
full advantage | 27 |
springer nature | 27 |
detection rate | 27 |
infected patients | 27 |
take full | 27 |
nh cl | 27 |
cov rna | 26 |
nipah virus | 26 |
disease control | 26 |
control sirna | 26 |
antibody titers | 26 |
ng ml | 26 |
rna copies | 26 |
coding region | 26 |
genomic sequences | 26 |
determine whether | 26 |
cytoplasmic tail | 26 |
clinical characteristics | 26 |
reference gene | 26 |
mrna expression | 26 |
significant differences | 26 |
rna recombination | 26 |
high throughput | 26 |
custom assay | 26 |
like viruses | 26 |
comparative analysis | 26 |
mouth disease | 26 |
viral titers | 26 |
significant difference | 26 |
primary human | 26 |
plc cells | 26 |
genomic rna | 26 |
hcv entry | 26 |
clinical specimens | 26 |
quantitative pcr | 26 |
multiplex pcr | 25 |
viral detection | 25 |
virus transmission | 25 |
reovirus infection | 25 |
specific antibodies | 25 |
sequence identity | 25 |
may also | 25 |
kivu province | 25 |
unfolded protein | 25 |
primer pair | 25 |
health organization | 25 |
felv infection | 25 |
human rhinovirus | 25 |
taken together | 25 |
sirnas targeting | 25 |
step rt | 25 |
mononuclear cells | 25 |
heat treatment | 25 |
using primers | 25 |
freely available | 25 |
molecular evolutionary | 25 |
determined using | 24 |
first time | 24 |
protective immunity | 24 |
tumor necrosis | 24 |
pcr amplification | 24 |
aplastic anemia | 24 |
protein synthesis | 24 |
plasmid dna | 24 |
induced apoptosis | 24 |
time quantitative | 24 |
culture supernatants | 24 |
dengue infection | 24 |
pedv strains | 24 |
cell death | 24 |
igm elisa | 24 |
gene encoding | 24 |
inhibitory effect | 24 |
transcription factors | 24 |
cd cells | 24 |
human airway | 24 |
dev ul | 24 |
luciferase reporter | 24 |
embryonated chicken | 24 |
envelope proteins | 24 |
bone marrow | 24 |
primary infection | 24 |
pa may | 24 |
lr cells | 24 |
staining pattern | 24 |
high level | 24 |
ebola virus | 24 |
large rafts | 24 |
ev infection | 24 |
hepatitis virus | 23 |
prrsv nsp | 23 |
thorough peer | 23 |
gut bacterial | 23 |
analysis revealed | 23 |
mg kg | 23 |
hsv infections | 23 |
cell types | 23 |
rapid diagnosis | 23 |
acid identity | 23 |
viral nucleic | 23 |
igg antibody | 23 |
acute lower | 23 |
standard deviation | 23 |
primer set | 23 |
ftd assay | 23 |
dna viruses | 23 |
cytopathic effect | 23 |
hepatoma cell | 23 |
spike glycoprotein | 23 |
serum albumin | 23 |
online submission | 23 |
nasal swab | 23 |
protein response | 23 |
cell activation | 23 |
convenient online | 23 |
genetic analysis | 23 |
peer review | 23 |
human infection | 23 |
age group | 23 |
central nervous | 23 |
upper respiratory | 23 |
genomic dna | 23 |
clinical features | 23 |
fetal calf | 23 |
molecular biology | 23 |
mdck cells | 23 |
also detected | 23 |
mouse model | 23 |
protein gene | 22 |
pol fidelity | 22 |
detected using | 22 |
positive patients | 22 |
human astroviruses | 22 |
gene sequences | 22 |
immediate publication | 22 |
years old | 22 |
hiv positive | 22 |
google scholar | 22 |
positive cells | 22 |
independent experiments | 22 |
age groups | 22 |
replicative homeostasis | 22 |
conserved among | 22 |
space constraints | 22 |
throat swab | 22 |
dna vaccine | 22 |
gene sequence | 22 |
avian coronavirus | 22 |
dengue viruses | 22 |
day post | 22 |
order nidovirales | 22 |
widely used | 22 |
specific antibody | 22 |
vaccine candidate | 22 |
statistical significance | 21 |
cotton rat | 21 |
airway epithelial | 21 |
water samples | 21 |
interfering rnas | 21 |
virus envelope | 21 |
cell responses | 21 |
asfv strains | 21 |
results suggest | 21 |
ethics committee | 21 |
selection pressure | 21 |
cells using | 21 |
serial dilutions | 21 |
gene region | 21 |
cleavage site | 21 |
cell lysates | 21 |
cell epitope | 21 |
ns gene | 21 |
escherichia coli | 21 |
ge healthcare | 21 |
thermo fisher | 21 |
barr virus | 21 |
sense rna | 21 |
entry inhibitors | 21 |
rna extraction | 21 |
coronavirus spike | 21 |
antibody responses | 21 |
cell viability | 21 |
infectious disease | 21 |
hek cells | 21 |
capsid protein | 21 |
canine distemper | 21 |
strains isolated | 21 |
primers used | 21 |
signaling pathways | 21 |
vesicular stomatitis | 21 |
recent years | 21 |
empty vector | 21 |
virus isolates | 21 |
immunofluorescence assay | 21 |
well plate | 20 |
hmpv infection | 20 |
time polymerase | 20 |
pandemic influenza | 20 |
human adenoviruses | 20 |
significantly lower | 20 |
causative agent | 20 |
antiviral response | 20 |
signaling pathway | 20 |
encephalomyocarditis virus | 20 |
blood mononuclear | 20 |
detection limit | 20 |
stomatitis virus | 20 |
sh gene | 20 |
infectious peritonitis | 20 |
confocal microscopy | 20 |
purified using | 20 |
growth factor | 20 |
informed consent | 20 |
treated cells | 20 |
matrix protein | 20 |
molecular weight | 20 |
consensus sequence | 20 |
using anti | 20 |
embryonated eggs | 20 |
acute diarrhea | 20 |
epithelial cell | 20 |
algerian strains | 20 |
enteritis virus | 20 |
significantly reduced | 20 |
domestic pigs | 20 |
cell count | 20 |
vp protein | 20 |
cell membrane | 20 |
mouse hepatitis | 20 |
polymerase activity | 20 |
feline infectious | 20 |
per well | 20 |
fisher scientific | 20 |
cysteine protease | 20 |
high mortality | 20 |
human parechovirus | 20 |
transmembrane proteins | 20 |
national institute | 20 |
horseradish peroxidase | 20 |
human astrovirus | 20 |
functional receptor | 20 |
surface expression | 20 |
antiviral effect | 20 |
sample size | 20 |
experimental infection | 20 |
total nucleic | 20 |
body weight | 20 |
results indicated | 19 |
bursal disease | 19 |
hela cells | 19 |
truncation mutants | 19 |
influenza vaccines | 19 |
hcmv infection | 19 |
low levels | 19 |
hcv replication | 19 |
mm tris | 19 |
binding sites | 19 |
mev infection | 19 |
authorized users | 19 |
dna vaccines | 19 |
virus titer | 19 |
pcr method | 19 |
analysis showed | 19 |
washed three | 19 |
innate immunity | 19 |
new cpv | 19 |
infectious hcvcc | 19 |
parainfluenza virus | 19 |
bcov rna | 19 |
virus control | 19 |
electronic supplementary | 19 |
different viruses | 19 |
dpb ie | 19 |
capsid proteins | 19 |
proteolytic processing | 19 |
lysis buffer | 19 |
note springer | 19 |
geographic distribution | 19 |
infectious bursal | 19 |
primary antibody | 19 |
genome sequences | 19 |
persistently infected | 19 |
infectious particles | 19 |
variant viral | 19 |
online version | 19 |
respiratory pathogens | 19 |
accession number | 19 |
interfering rna | 19 |
secondary structure | 19 |
will help | 19 |
human disease | 19 |
dromedary camels | 19 |
sequence alignments | 19 |
high levels | 19 |
contains supplementary | 19 |
tissue samples | 19 |
nucleotide identity | 19 |
viral shedding | 19 |
field strains | 19 |
field isolates | 19 |
patchouli alcohol | 19 |
three different | 18 |
distemper virus | 18 |
cytoplasmic domain | 18 |
transcription factor | 18 |
cdv vaccine | 18 |
enveloped viruses | 18 |
free water | 18 |
neutralizing antibody | 18 |
data analysis | 18 |
pedv infection | 18 |
reaction mixture | 18 |
mortality rate | 18 |
life technologies | 18 |
complete genomic | 18 |
host immune | 18 |
mers cases | 18 |
usage bias | 18 |
final concentration | 18 |
type ii | 18 |
influenza vaccine | 18 |
tested positive | 18 |
vacv ihd | 18 |
pcr system | 18 |
virus fusion | 18 |
xmap assay | 18 |
disease severity | 18 |
severe fever | 18 |
nonstructural proteins | 18 |
animal experiments | 18 |
ifitm induced | 18 |
targeted rna | 18 |
family coronaviridae | 18 |
protein level | 18 |
wide range | 18 |
virus rna | 18 |
may play | 18 |
zoonotic viruses | 18 |
life cycle | 18 |
recombinant protein | 18 |
risk factors | 18 |
negative controls | 18 |
phosphate buffered | 18 |
children aged | 18 |
sh protein | 18 |
genetic characterization | 18 |
virus gene | 18 |
intergenic region | 18 |
rabbit anti | 18 |
thrombocytopenia syndrome | 18 |
np protein | 18 |
extracted using | 18 |
molecular evolution | 18 |
evolutionary genetics | 18 |
protein identification | 18 |
blood cells | 18 |
two distinct | 18 |
results obtained | 18 |
cytopathic effects | 18 |
newly discovered | 18 |
pcr reaction | 17 |
genome sequencing | 17 |
interferon gamma | 17 |
alpha beta | 17 |
cultured cells | 17 |
molecular assays | 17 |
respiratory diseases | 17 |
mm nacl | 17 |
clinical diagnosis | 17 |
cell clones | 17 |
vp animal | 17 |
yellow fever | 17 |
protein kinase | 17 |
among different | 17 |
using real | 17 |
genomic sequence | 17 |
reverse primer | 17 |
results demonstrated | 17 |
ifitm specific | 17 |
coronavirus infectious | 17 |
gene products | 17 |
final volume | 17 |
conducted using | 17 |
human cells | 17 |
among children | 17 |
associated coronavirus | 17 |
aplastic anaemia | 17 |
recombinant proteins | 17 |
antiviral therapy | 17 |
large number | 17 |
hsv replication | 17 |
ha protein | 17 |
nucleolar localization | 17 |
kindly provided | 17 |
wild type | 17 |
genetics analysis | 17 |
hendra virus | 17 |
viral diseases | 17 |
biosafety level | 17 |
mediated endocytosis | 17 |
transmembrane domain | 17 |
reference strains | 17 |
crfk cells | 17 |
lung tissues | 17 |
one sample | 17 |
like receptor | 17 |
gastroenteritis coronavirus | 17 |
surface protein | 17 |
fusion domain | 17 |
commonly used | 17 |
yc pedv | 17 |
vero cell | 16 |
transferrin receptor | 16 |
expression system | 16 |
nasopharyngeal aspirates | 16 |
pcr detection | 16 |
virus vaccine | 16 |
dependent manner | 16 |
throat washes | 16 |
several studies | 16 |
viet nam | 16 |
position th | 16 |
different cell | 16 |
least one | 16 |
pcr kit | 16 |
human plasma | 16 |
protein species | 16 |
neuraminidase inhibitors | 16 |
novel virus | 16 |
cdna synthesis | 16 |
flocked swabs | 16 |
lethal challenge | 16 |
nonstructural protein | 16 |
children hospitalized | 16 |
mice immunized | 16 |
host species | 16 |
cell signaling | 16 |
forward primer | 16 |
human hepatoma | 16 |
rhesus monkeys | 16 |
cells showed | 16 |
length genome | 16 |
study showed | 16 |
swab samples | 16 |
chicken embryos | 16 |
data presented | 16 |
molecular mass | 16 |
experimentally infected | 16 |
calculated using | 16 |
relative infection | 16 |
diagnostic methods | 16 |
virus challenge | 16 |
virus production | 16 |
mers coronavirus | 16 |
copy numbers | 16 |
oxide synthase | 16 |
different regions | 16 |
cytomegalovirus infection | 16 |
weeks post | 16 |
cycle sequencing | 16 |
rna mini | 16 |
human macrophages | 16 |
detection system | 16 |
vp vp | 16 |
two viruses | 16 |
log tcid | 16 |
dose group | 16 |
described elsewhere | 16 |
northeastern china | 16 |
domain ii | 16 |
coronavirus infections | 16 |
binding protein | 16 |
respiratory samples | 16 |
rd cells | 16 |
rabbit polyclonal | 16 |
amplified using | 16 |
higher levels | 16 |
also known | 16 |
expression vectors | 16 |
healthy controls | 16 |
binding domain | 15 |
fold change | 15 |
transmembrane protein | 15 |
gene transcription | 15 |
standard deviations | 15 |
coding sequence | 15 |
copy number | 15 |
target cell | 15 |
conserved regions | 15 |
expression plasmids | 15 |
field samples | 15 |
polyclonal antibodies | 15 |
random multiplex | 15 |
duplex real | 15 |
genetic variation | 15 |
multiplex rt | 15 |
iav infected | 15 |
recent studies | 15 |
even though | 15 |
psd spectra | 15 |
small hydrophobic | 15 |
chronic hepatitis | 15 |
pfu ml | 15 |
stranded dna | 15 |
i ifns | 15 |
severe respiratory | 15 |
hours post | 15 |
copies reaction | 15 |
poultry industry | 15 |
alexa fluor | 15 |
fluorescence microscopy | 15 |
fluorescence intensity | 15 |
animal model | 15 |
aedes aegypti | 15 |
north america | 15 |
human parainfluenza | 15 |
sirna group | 15 |
also observed | 15 |
weight loss | 15 |
results indicate | 15 |
ml penicillin | 15 |
rice plants | 15 |
dna sequencing | 15 |
replication cycle | 15 |
stained using | 15 |
total antibody | 15 |
type strain | 15 |
antigenic site | 15 |
coronavirus genome | 15 |
sucrose gradient | 15 |
candidate reference | 15 |
final extension | 15 |
cell tropism | 15 |
domain iii | 15 |
viral genomic | 15 |
sequence data | 15 |
gene therapy | 15 |
positive specimens | 15 |
protein complex | 15 |
winter dysentery | 15 |
viral respiratory | 15 |
recombinant virus | 15 |
ibv spike | 15 |
cause severe | 15 |
transcription polymerase | 15 |
isothermal amplification | 15 |
dengue vaccine | 15 |
reticulum stress | 15 |
severe disease | 15 |
viral copies | 15 |
three groups | 15 |
ifitm expression | 15 |
sybr green | 15 |
four times | 15 |
written informed | 15 |
human immune | 15 |
pr ha | 15 |
human cases | 15 |
house real | 15 |
pcr analysis | 15 |
virus adsorption | 15 |
bp fragment | 15 |
infection index | 15 |
i ifn | 15 |
molecular mechanisms | 15 |
parainfluenza viruses | 14 |
different strains | 14 |
highly contagious | 14 |
different time | 14 |
sigmodon hispidus | 14 |
regulatory factor | 14 |
ml streptomycin | 14 |
positive rate | 14 |
may lead | 14 |
reverse primers | 14 |
known human | 14 |
identified using | 14 |
cov orf | 14 |
uninfected cells | 14 |
reovirus replication | 14 |
novel viruses | 14 |
nucleocapsid gene | 14 |
cycling conditions | 14 |
also used | 14 |
antiviral state | 14 |
arabian peninsula | 14 |
rsv infection | 14 |
respiratory symptoms | 14 |
rnai screen | 14 |
southeast asia | 14 |
cells stably | 14 |
emerging viruses | 14 |
hav genome | 14 |
pg ml | 14 |
ethics approval | 14 |
respiratory distress | 14 |
chop expression | 14 |
lycorine treatment | 14 |
dna virus | 14 |
higher viral | 14 |
case definition | 14 |
vaccine development | 14 |
epidemic diarrhoea | 14 |
median age | 14 |
fecal specimens | 14 |
significantly increased | 14 |
many countries | 14 |
rma assay | 14 |
false positive | 14 |
spiked swabs | 14 |
enteric viruses | 14 |
inhibitory activity | 14 |
neurological symptoms | 14 |
inhibitory effects | 14 |
rna levels | 14 |
dengue cases | 14 |
crf ag | 14 |
extracted rna | 14 |
dna microarray | 14 |
extraction kit | 14 |
vaccinated mice | 14 |
agricultural university | 14 |
turbinate nasal | 14 |
well known | 14 |
common cold | 14 |
antibody response | 14 |
genetically distinct | 14 |
virus particle | 14 |
expressing cells | 14 |
od values | 14 |
genotype ii | 14 |
measles virus | 14 |
murine leukemia | 14 |
high viral | 14 |
residual infectivity | 14 |
phylogenetic relationships | 14 |
abi prism | 14 |
qiaamp viral | 14 |
oral cavity | 14 |
induced ifn | 14 |
broad spectrum | 14 |
hemagglutinating encephalomyelitis | 14 |
duck tuva | 14 |
genotype i | 14 |
interferon production | 14 |
orf ab | 14 |
genbank database | 14 |
experimental design | 14 |
culture medium | 14 |
interferon beta | 14 |
type strains | 14 |
considered statistically | 14 |
type virus | 14 |
df cases | 14 |
protein sequences | 14 |
master mix | 14 |
sequence conservation | 14 |
every step | 14 |
lmp promoter | 14 |
conventional pcr | 14 |
multiple reference | 14 |
nl rptec | 14 |
human population | 14 |
molecular markers | 14 |
national institutes | 14 |
sanger sequencing | 14 |
different genotypes | 14 |
six years | 14 |
fold higher | 14 |
red blood | 14 |
tfr mrna | 14 |
survival rates | 14 |
renal epithelial | 14 |
human polyomaviruses | 13 |
different types | 13 |
coronavirus associated | 13 |
solid phase | 13 |
cp transfusion | 13 |
constructed using | 13 |
single amino | 13 |
feline coronavirus | 13 |
diabetes mellitus | 13 |
origin influenza | 13 |
human viruses | 13 |
attenuated vaccine | 13 |
ill patients | 13 |
virus neutralization | 13 |
like virus | 13 |
od nm | 13 |
virus genome | 13 |
protease activity | 13 |
close contact | 13 |
immunocompromised patients | 13 |
side effects | 13 |
carboxyl terminal | 13 |
data showed | 13 |
natural selection | 13 |
positive results | 13 |
sirnas treated | 13 |
stably expressing | 13 |
lysosomotropic agents | 13 |
generation sequencing | 13 |
monkey kidney | 13 |
antibiotic cocktail | 13 |
serially diluted | 13 |
stainless steel | 13 |
lang virions | 13 |
dna vaccination | 13 |
viral disease | 13 |
statistical analyses | 13 |
diarrhoea virus | 13 |
optical density | 13 |
genomic characterization | 13 |
acid substitutions | 13 |
cellular receptors | 13 |
pathogenic avian | 13 |
usage pattern | 13 |
time point | 13 |
blood donors | 13 |
new york | 13 |
research institute | 13 |
wide rnai | 13 |
iav infection | 13 |
hmpv igg | 13 |
healthy children | 13 |
purification kit | 13 |
se protein | 13 |
mlv binding | 13 |
human enterovirus | 13 |
respiratory specimens | 13 |
glycosylation site | 13 |
associated aplastic | 13 |
expression level | 13 |
entry factors | 13 |
negative results | 13 |
immunized mice | 13 |
positively selected | 13 |
qpcr assay | 13 |
negative sera | 13 |
prepared using | 13 |
goose parvovirus | 13 |
acute infection | 13 |
secondary antibodies | 13 |
genome organization | 13 |
encephalomyelitis virus | 13 |
treated group | 13 |
fold increase | 13 |
giant panda | 13 |
heparan sulfate | 13 |
virome composition | 13 |
na protein | 13 |
whole blood | 13 |
transfection reagent | 13 |
previously shown | 13 |
coronavirus hku | 13 |
ifitm proteins | 13 |
expressing pgpu | 13 |
rna genome | 13 |
tested negative | 13 |
considered significant | 13 |
protein genes | 13 |
washed twice | 13 |
human transmission | 13 |
tract disease | 13 |
months old | 13 |
virus assembly | 13 |
six months | 13 |
data suggest | 13 |
maximum parsimony | 13 |
gfp nc | 13 |
study group | 13 |
elisa kit | 13 |
also found | 13 |
hrsv igg | 13 |
pseudorabies virus | 13 |
restriction enzyme | 13 |
inactivated viral | 13 |
pathogenic viruses | 13 |
antiviral activities | 12 |
anal swabs | 12 |
pcr primers | 12 |
two mirnas | 12 |
assay system | 12 |
dna copies | 12 |
healthy volunteers | 12 |
new human | 12 |
wt mice | 12 |
laboratory testing | 12 |
ifitm protein | 12 |
roche diagnostics | 12 |
jev persistent | 12 |
i fragment | 12 |
antiviral drugs | 12 |
complete protection | 12 |
iii viral | 12 |
naturally infected | 12 |
bgl i | 12 |
within days | 12 |
old chickens | 12 |
one step | 12 |
health care | 12 |
data generated | 12 |
immune complexes | 12 |
quantified using | 12 |
apoptotic cells | 12 |
fluorescence microscope | 12 |
hiv infection | 12 |
protein ns | 12 |
infected rice | 12 |
foster city | 12 |
growth kinetics | 12 |
sequenced using | 12 |
systematic review | 12 |
distress syndrome | 12 |
protease inhibitor | 12 |
taq dna | 12 |
medical research | 12 |
infection rate | 12 |
tissue tropism | 12 |
vehicle control | 12 |
coronavirus ibv | 12 |
southern vietnam | 12 |
fusion loops | 12 |
tick fever | 12 |
cruz biotechnology | 12 |
universal primer | 12 |
viral diarrhea | 12 |
sample collection | 12 |
highly divergent | 12 |
inhibit viral | 12 |
disease associated | 12 |
ctl epitope | 12 |
transmembrane domains | 12 |
much higher | 12 |
serum dilution | 12 |
african green | 12 |
blot assay | 12 |
mrna levels | 12 |
four hours | 12 |
important roles | 12 |
ul protein | 12 |
whole genome | 12 |
colorado tick | 12 |
chicken embryo | 12 |
acute gastroenteritis | 12 |
different groups | 12 |
cell receptor | 12 |
gastrointestinal tract | 12 |
cp values | 12 |
lines represent | 12 |
mediated isothermal | 12 |
emerging infectious | 12 |
elution buffer | 12 |
three independent | 12 |
reaction mix | 12 |
study design | 12 |
dengue activity | 12 |
next generation | 12 |
developed using | 12 |
nucleotide substitutions | 12 |
cell growth | 12 |
four different | 12 |
gene silencing | 12 |
resistance mutations | 12 |
copies per | 12 |
intracellular hcv | 12 |
virus receptor | 12 |
using pcr | 12 |
investigate whether | 12 |
cellular immune | 12 |
synthetic peptides | 12 |
among patients | 12 |
severe influenza | 12 |
obtained using | 12 |
renilla luciferase | 12 |
human lung | 12 |
vertical transmission | 12 |
tgev infection | 12 |
sequence diversity | 12 |
hcmv gb | 12 |
coli bl | 12 |
surface proteins | 12 |
transcriptase pcr | 12 |
cell type | 12 |
cells compared | 12 |
protein based | 12 |
rich microdomains | 12 |
cycle threshold | 12 |
aedes albopictus | 12 |
examined using | 12 |
hpv prevalence | 12 |
experimental conditions | 12 |
relative humidity | 12 |
respiratory coronavirus | 12 |
pbs containing | 12 |
interferon response | 12 |
located within | 12 |
viruses including | 12 |
i i | 12 |
major cause | 12 |
antiviral agents | 12 |
efficient replication | 12 |
sore throat | 12 |
virus proteins | 12 |
autophagosomes induced | 12 |
molecular detection | 12 |
viruses detected | 12 |
control cells | 12 |
stool sample | 12 |
etiologic agent | 12 |
protein sequence | 12 |
pregnant women | 12 |
recent study | 12 |
influenza infection | 12 |
cov genome | 12 |
mill homogenization | 12 |
progeny virus | 12 |
point mutations | 12 |
cells treated | 12 |
virus infectivity | 12 |
plaque assays | 12 |
detection rates | 12 |
mouse monoclonal | 12 |
based vaccines | 12 |
clinical manifestations | 12 |
primer pairs | 12 |
graphpad prism | 12 |
cov rt | 12 |
post inoculation | 12 |
south america | 12 |
least two | 12 |
international committee | 12 |
also present | 12 |
nucleotide position | 12 |
prrsv infection | 12 |
marburg virus | 11 |
hiv negative | 11 |
nk cell | 11 |
acid residues | 11 |
fatal cases | 11 |
using either | 11 |
infectious viruses | 11 |
hae cultures | 11 |
furin cleavage | 11 |
european bats | 11 |
second round | 11 |
stem domain | 11 |
cell proliferation | 11 |
sucrose cushion | 11 |
conserved region | 11 |
viral spread | 11 |
acquired infections | 11 |
immune status | 11 |
superscript iii | 11 |
high fidelity | 11 |
macrophage activation | 11 |
immunochromatographic strips | 11 |
interferon alpha | 11 |
viral clearance | 11 |
previously published | 11 |
mouse macrophages | 11 |
relatively high | 11 |
reference sequences | 11 |
san diego | 11 |
fluorescent protein | 11 |
much lower | 11 |
ion channel | 11 |
epidemiological studies | 11 |
human papillomaviruses | 11 |
samples contained | 11 |
cns infection | 11 |
ha gene | 11 |
positive sera | 11 |
using molecular | 11 |
time qpcr | 11 |
two assays | 11 |
performed according | 11 |
severe pneumonia | 11 |
consensus ha | 11 |
osterhaus ad | 11 |
proteomics computational | 11 |
airway epithelium | 11 |
mass spectrometry | 11 |
activation plasmid | 11 |
viral life | 11 |
host innate | 11 |
febrile illness | 11 |
infected animals | 11 |
hpv positive | 11 |
equine encephalitis | 11 |
mice vaccinated | 11 |
modified eagle | 11 |
lymph nodes | 11 |
commercially available | 11 |
broiler chickens | 11 |
bhk cells | 11 |
virus using | 11 |
differential diagnosis | 11 |
may serve | 11 |
conformational changes | 11 |
washed times | 11 |
infectious agents | 11 |
cells co | 11 |
signal peptide | 11 |
binding lectin | 11 |
simple method | 11 |
four days | 11 |
nasal flocked | 11 |
first step | 11 |
aligned using | 11 |
high specificity | 11 |
jev persistently | 11 |
metagenomic analysis | 11 |
ct value | 11 |
dn ds | 11 |
hypervariable region | 11 |
eagle medium | 11 |
transplant recipients | 11 |
recombinant vaccinia | 11 |
healthy adults | 11 |
zoster virus | 11 |
accessory proteins | 11 |
nasopharyngeal aspirate | 11 |
polymerase gene | 11 |
may explain | 11 |
wwihs scores | 11 |
i interferons | 11 |
south china | 11 |
untranslated region | 11 |
pseudotyped virus | 11 |
higher concentrations | 11 |
human polyomavirus | 11 |
cdna clone | 11 |
infectious hadv | 11 |
zn levels | 11 |
pcr reactions | 11 |
sequences using | 11 |
ibv antigens | 11 |
ul gene | 11 |
infection among | 11 |
air samples | 11 |
recombinant ibv | 11 |
rice stripe | 11 |
first days | 11 |
circulating strains | 11 |
polyclonal antisera | 11 |
porous surfaces | 11 |
friendship hospital | 11 |
expression plasmid | 11 |
mediated ifn | 11 |
transcriptase polymerase | 11 |
cmv promoter | 11 |
indirect igg | 11 |
dna sequences | 11 |
viral pneumonia | 11 |
indicated times | 11 |
virus serotype | 11 |
viral etiology | 11 |
confirmed cases | 11 |
hispidus cell | 11 |
specific pathogen | 11 |
mononuclear phagocytes | 11 |
also reported | 11 |
using mega | 11 |
science foundation | 11 |
total volume | 11 |
human herpesvirus | 11 |
sialic acids | 11 |
dna poly | 11 |
clinical presentation | 11 |
positive wwihs | 11 |
antiviral effects | 11 |
observed among | 11 |
hemagglutination inhibition | 11 |
conserved sites | 11 |
healthcare workers | 11 |
dengue type | 11 |
vector control | 11 |
viral infectivity | 11 |
may provide | 11 |
post transfection | 11 |
corresponding author | 11 |
mm mgcl | 11 |
five times | 11 |
beta interferon | 11 |
acid changes | 11 |
blood cell | 11 |
denv replication | 11 |
dengue patients | 11 |
three weeks | 11 |
newly isolated | 11 |
using recombinant | 11 |
nitrocellulose membrane | 11 |
culture system | 11 |
mammalian cell | 11 |
pa treatment | 11 |
samples using | 11 |
fusion activity | 11 |
plasma samples | 11 |
receptor specificity | 11 |
prospective study | 11 |
using confocal | 11 |
two methods | 11 |
viral hepatitis | 11 |
critically ill | 11 |
converting enzyme | 11 |
viral gene | 11 |
treated mice | 11 |
animal welfare | 11 |
seasonal influenza | 11 |
epidemiological surveillance | 11 |
early stage | 11 |
computational analyses | 11 |
age range | 10 |
virus discovery | 10 |
first report | 10 |
gold standard | 10 |
genome equivalents | 10 |
scale bars | 10 |
realtime pcr | 10 |
induced activation | 10 |
proteins encoded | 10 |
low viral | 10 |
linked sialic | 10 |
green monkey | 10 |
virus date | 10 |
acute pharyngitis | 10 |
virus gp | 10 |
commercial kit | 10 |
virus isolate | 10 |
extension step | 10 |
randomly selected | 10 |
acid substitution | 10 |
cell survival | 10 |
sequences obtained | 10 |
reovirus uncoating | 10 |
three washes | 10 |
tgev genome | 10 |
genetic material | 10 |
antibody levels | 10 |
green fluorescent | 10 |
entry process | 10 |
immunodominant region | 10 |
conjugated anti | 10 |
using lipofectamine | 10 |
multiple infections | 10 |
muscle tissues | 10 |
ibv antigen | 10 |
pcr following | 10 |
virus ns | 10 |
gradient centrifugation | 10 |
showed high | 10 |
specific igg | 10 |
antibody detection | 10 |
genotype iii | 10 |
assessed using | 10 |
viral titer | 10 |
sequences available | 10 |
quantitative detection | 10 |
infected vero | 10 |
frugivorous bats | 10 |
study protocol | 10 |
chinese academy | 10 |
study period | 10 |
study demonstrated | 10 |
stock solution | 10 |
naturally occurring | 10 |
final version | 10 |
protease inhibitors | 10 |
human virus | 10 |
newly identified | 10 |
single nucleotide | 10 |
filamentous staining | 10 |
elisa kits | 10 |
coronavirus disease | 10 |
lower limit | 10 |
software version | 10 |
sandwich elisa | 10 |
antimicrobial peptides | 10 |
mv lu | 10 |
subcellular localization | 10 |
first round | 10 |
pseudotyping system | 10 |
feline kidney | 10 |
jilin province | 10 |
detection kit | 10 |
culture supernatant | 10 |
intensive care | 10 |
giant pandas | 10 |
host factor | 10 |
ga strains | 10 |
virus stock | 10 |
genetic variability | 10 |
yeast two | 10 |
small sample | 10 |
human monoclonal | 10 |
oropharyngeal swabs | 10 |
geq ml | 10 |
identified epitope | 10 |
high sensitivity | 10 |
ge copies | 10 |
specific immune | 10 |
ibv genome | 10 |
expression patterns | 10 |
mhv spike | 10 |
method using | 10 |
proviral dna | 10 |
bat coronaviruses | 10 |
multiple organ | 10 |
sirna treated | 10 |
host proteins | 10 |
gadd aa | 10 |
situ hybridization | 10 |
mink enteritis | 10 |
internal genes | 10 |
porcine circovirus | 10 |
emergency department | 10 |
currently available | 10 |
protein expressed | 10 |
methods section | 10 |
reduction assay | 10 |
pathogen free | 10 |
two subunits | 10 |
patients infected | 10 |
parechovirus type | 10 |
frequent detection | 10 |
natural science | 10 |
nl orf | 10 |
test results | 10 |
cells stained | 10 |
successfully amplified | 10 |
otherwise healthy | 10 |
killer cells | 10 |
hexon gene | 10 |
positive children | 10 |
newly emerged | 10 |
detection methods | 10 |
antigen detection | 10 |
infected individuals | 10 |
dhf epidemics | 10 |
cell carcinoma | 10 |
viral aetiology | 10 |
significantly different | 10 |
coronavirus oc | 10 |
luciferase assay | 10 |
avian cells | 10 |
isolated strains | 10 |
viral antigens | 10 |
samples showed | 10 |
consensus sequences | 10 |
day pi | 10 |
technical assistance | 10 |
pvp plasmid | 10 |
transmission electron | 10 |
human primates | 10 |
gut virome | 10 |
untreated control | 10 |
generated using | 10 |
mtt assay | 10 |
serine protease | 10 |
wide variety | 10 |
sequencing kit | 10 |
liver cells | 10 |
denv infection | 10 |
feline immunodeficiency | 10 |
high prevalence | 10 |
thank dr | 10 |
minute virus | 10 |
mbl concentrations | 10 |
substitutions per | 10 |
reported previously | 10 |
map vaccine | 10 |
cov infections | 10 |
animal health | 10 |
dhf dss | 10 |
flaccid paralysis | 10 |
viruses tested | 10 |
first reported | 10 |
viral persistence | 10 |
dnase i | 10 |
ibv mass | 10 |
results demonstrate | 10 |
also performed | 10 |
control groups | 10 |
essential medium | 10 |
serological evidence | 10 |
rtpcr assay | 10 |
new england | 10 |
novel influenza | 10 |
multiplex reverse | 10 |
broad range | 10 |
huh cell | 10 |
low level | 10 |
highly specific | 10 |
cost effective | 10 |
virus titration | 10 |
expression analysis | 10 |
lc puncta | 10 |
usage variation | 10 |
beijing friendship | 10 |
initiation codon | 10 |
likelihood method | 10 |
target sequence | 10 |
ibv ark | 10 |
ctl epitopes | 10 |
human cell | 10 |
fap primers | 10 |
animal care | 9 |
small mammals | 9 |
highly variable | 9 |
prv infection | 9 |
reduced viral | 9 |
singleplex xmap | 9 |
nl amsterdam | 9 |
human monocytes | 9 |
immunized group | 9 |
signaling technology | 9 |
length polymorphism | 9 |
plasmids encoding | 9 |
full genome | 9 |
viral agents | 9 |
short interfering | 9 |
host genetic | 9 |
surveillance system | 9 |
acidic ph | 9 |
disease viruses | 9 |
tested using | 9 |
studies using | 9 |
severe cases | 9 |
polyacrylamide gel | 9 |
human rhinoviruses | 9 |
presenting cells | 9 |
ubq gapdh | 9 |
qualitative pcr | 9 |
viral pathogen | 9 |
rneasy mini | 9 |
virus protein | 9 |
endothelial cell | 9 |
confidence intervals | 9 |
recombinant plasmids | 9 |
journal submit | 9 |
tool helps | 9 |
induce ifn | 9 |
mrna level | 9 |
specific viruses | 9 |
dna extracted | 9 |
antiviral treatment | 9 |
npa specimens | 9 |
using rt | 9 |
submission inquiries | 9 |
lung tissue | 9 |
beckman coulter | 9 |
previous reports | 9 |
using two | 9 |
viruses using | 9 |
sequence similarity | 9 |
co incubator | 9 |
animal studies | 9 |
primer sequences | 9 |
ten buffer | 9 |
inhibitory peptides | 9 |
based indirect | 9 |
first two | 9 |
dendritic cell | 9 |
infected samples | 9 |
target genes | 9 |
spike serum | 9 |
pseudotyped particles | 9 |
filamentous structures | 9 |
hadv type | 9 |
infected hek | 9 |
cells per | 9 |
caat box | 9 |
protective efficacy | 9 |
infectious laryngotracheitis | 9 |
microrna mir | 9 |
apparently healthy | 9 |
particle group | 9 |
also associated | 9 |
coronavirus replication | 9 |
fragment length | 9 |
hadv infections | 9 |
virus glycoproteins | 9 |
virus spike | 9 |
eukaryotic expression | 9 |
transport media | 9 |
findings suggest | 9 |
previously undescribed | 9 |
gut microbiome | 9 |
culture plates | 9 |
reference sequence | 9 |
structural genes | 9 |
forming units | 9 |
antiviral drug | 9 |
epidemic potential | 9 |
oligonucleotide microarray | 9 |
simian virus | 9 |
fusion peptide | 9 |
ne inhibitor | 9 |
higher level | 9 |
provide protection | 9 |
eukaryotic cells | 9 |
cellular proteins | 9 |
old embryonated | 9 |
major histocompatibility | 9 |
crispr activation | 9 |
rrna amplicon | 9 |
influenza pandemic | 9 |
untreated cells | 9 |
conjugated secondary | 9 |
analysis indicated | 9 |
safety assessment | 9 |
human bronchial | 9 |
fruit bat | 9 |
interferon regulatory | 9 |
glycoprotein pseudotyped | 9 |
carrier rna | 9 |
based vaccine | 9 |
using western | 9 |
lymph node | 9 |
antibody sandwich | 9 |
splice site | 9 |
avian leukosis | 9 |
viral cultures | 9 |
vietnamese cpv | 9 |
protein interactions | 9 |
standard curves | 9 |
entry receptor | 9 |
specific monoclonal | 9 |
energy metabolism | 9 |
recombinant nucleocapsid | 9 |
positive feed | 9 |
effective antiviral | 9 |
based real | 9 |
high fever | 9 |
early stages | 9 |
viral antigen | 9 |
rhinovirus species | 9 |
indirect immunofluorescence | 9 |
acute hepatitis | 9 |
shrna expression | 9 |
prototype strain | 9 |
epidemiology studies | 9 |
results suggested | 9 |
transfection efficiency | 9 |
signal intensity | 9 |
limiting dilution | 9 |
commercial elisa | 9 |
intestinal epithelial | 9 |
experimental animal | 9 |
tetravalent dengue | 9 |
epitope defined | 9 |
virus nucleocapsid | 9 |
ethidium bromide | 9 |
herpes virus | 9 |
differences observed | 9 |
mm edta | 9 |
immediate early | 9 |
deep sequencing | 9 |
two strains | 9 |
relevant journal | 9 |
kidney epithelial | 9 |
probes used | 9 |
virus isolated | 9 |
prrsv nsps | 9 |
fluorescently labeled | 9 |
growth medium | 9 |
viral transport | 9 |
normalized signals | 9 |
visualized using | 9 |
play important | 9 |
ct values | 9 |
indirect igm | 9 |
stop codons | 9 |
fold changes | 9 |
incubated overnight | 9 |
highly virulent | 9 |
infected plc | 9 |
evaluated using | 9 |
rhesus monkey | 9 |
supply system | 9 |
different species | 9 |
i vfp | 9 |
virus structural | 9 |
differences among | 9 |
ab test | 9 |
group piglet | 9 |
mutation rate | 9 |
selector tool | 9 |
cov genomes | 9 |
disease pathogenesis | 9 |
rna sequences | 9 |
reactive oxygen | 9 |
antigenic diversity | 9 |
specific cd | 9 |
initiation factor | 9 |
bacterial community | 9 |
sirna targeting | 9 |
haemorrhagic fever | 9 |
positional effects | 9 |
bacterial infections | 9 |
significantly decreased | 9 |
acid differences | 9 |
hadv particles | 9 |
hmpv particles | 9 |
double stranded | 9 |
live attenuated | 9 |
rabies virus | 9 |
single stranded | 9 |
also examined | 9 |
virus identification | 9 |
qpcr analysis | 9 |
ii vfp | 9 |
regulated genes | 9 |
virus group | 9 |
data collection | 9 |
target gene | 9 |
medical sciences | 9 |
humoral immune | 9 |
oligonucleotide primers | 9 |
may increase | 9 |
experimental studies | 9 |
viral mrna | 9 |
may therefore | 9 |
normalized signal | 9 |
host restriction | 9 |
infected macrophages | 9 |
hpv detection | 9 |
twice daily | 9 |
swab specimens | 9 |
step real | 9 |
repeated three | 9 |
virus neuraminidase | 9 |
infectious viral | 9 |
extracellular domain | 9 |
many years | 9 |
inhibition rate | 9 |
using appropriate | 9 |
common respiratory | 9 |
blood transfusion | 9 |
firefly luciferase | 9 |
accept pre | 9 |
approximately kda | 9 |
vlp formation | 9 |
virus persistence | 9 |
strains circulating | 9 |
cov spike | 9 |
cell cycle | 9 |
igg elisa | 9 |
murine coronavirus | 9 |
sirna combinations | 9 |
dengue disease | 9 |
glycosylation mutants | 9 |
mosquito cells | 9 |
acute flaccid | 9 |
significant increase | 9 |
dengue epidemics | 9 |
tract samples | 9 |
molecular testing | 9 |
th day | 9 |
rna transcripts | 9 |
one virus | 9 |
china agricultural | 9 |
following infection | 9 |
proinflammatory cytokines | 9 |
ifitm crispr | 9 |
ecor i | 9 |
hpv infection | 9 |
using virus | 9 |
type infection | 9 |
exhaled breath | 9 |
duck enteritis | 9 |
melting curve | 9 |
genome analysis | 9 |
specific host | 9 |
flow cytometric | 9 |
increased virulence | 9 |
biological characteristics | 9 |
pcr based | 9 |
borne viruses | 9 |
cells incubated | 9 |
np swab | 9 |
serine proteases | 9 |
england biolabs | 9 |
measured using | 9 |
pig industry | 9 |
fruit bats | 9 |
ibv infection | 9 |
two weeks | 9 |
like protease | 9 |
ibv ab | 9 |
veterinary research | 9 |
low ph | 9 |
pediatric patients | 8 |
negative samples | 8 |
gpv dna | 8 |
amplified products | 8 |
highly prevalent | 8 |
dead birds | 8 |
one hour | 8 |
quantitative reverse | 8 |
analytical sensitivity | 8 |
inactivated vacv | 8 |
data suggested | 8 |
likelihood phylogenetic | 8 |
mouse peritoneal | 8 |
use committee | 8 |
like illnesses | 8 |
phosphate buffer | 8 |
vast majority | 8 |
like receptors | 8 |
peritonitis virus | 8 |
normal bhk | 8 |
primary antibodies | 8 |
infectious sars | 8 |
broiler flocks | 8 |
two groups | 8 |
recombinant human | 8 |
genetic lineages | 8 |
host interactions | 8 |
puerto rico | 8 |
smooth muscle | 8 |
transferred onto | 8 |
syncytium formation | 8 |
day old | 8 |
rn protein | 8 |
surviving mice | 8 |
glycoprotein gene | 8 |
prrsv ch | 8 |
array assay | 8 |
may contribute | 8 |
human metapneumoviruses | 8 |
exact test | 8 |
polyclonal antiserum | 8 |
various cell | 8 |
i site | 8 |
rice black | 8 |
immune complex | 8 |
simian immunodeficiency | 8 |
similar results | 8 |
respiratory illnesses | 8 |
ex taq | 8 |
rptec pp | 8 |
dengue haemorrhagic | 8 |
amplification products | 8 |
elisa system | 8 |
hepatocellular carcinoma | 8 |
pdm virus | 8 |
infective dose | 8 |
mouse cells | 8 |
mice infected | 8 |
sirna transfection | 8 |
sucrose interface | 8 |
transmission potential | 8 |
also demonstrated | 8 |
confidence interval | 8 |
infections among | 8 |
killer cell | 8 |
hepg cells | 8 |
several viral | 8 |
significantly inhibited | 8 |
clinical presentations | 8 |
laboratory animal | 8 |
inducible nitric | 8 |
weight gain | 8 |
data sets | 8 |
host tropism | 8 |
protein levels | 8 |
host interaction | 8 |
per gene | 8 |
children years | 8 |
genomic mrnas | 8 |
risk factor | 8 |
serum antibodies | 8 |
dashed line | 8 |
rna extracted | 8 |
inhibition assay | 8 |
enterovirus serotypes | 8 |
actin mrna | 8 |
density lipoprotein | 8 |
control measures | 8 |
using reverse | 8 |
molecular diagnosis | 8 |
microplate reader | 8 |
observed using | 8 |
containing fetal | 8 |
acid amplification | 8 |
adhesion molecule | 8 |
host defence | 8 |
treated groups | 8 |
variation among | 8 |
recombinant expression | 8 |
human host | 8 |
collected samples | 8 |
better understanding | 8 |
inhibit mev | 8 |
two cell | 8 |
epidermal growth | 8 |
neuraminidase inhibitor | 8 |
low density | 8 |
analysis based | 8 |
contact tracing | 8 |
study demonstrates | 8 |
different lineages | 8 |
recognition receptors | 8 |
control virus | 8 |
surface glycoproteins | 8 |
mouse antibody | 8 |
koalas harbouring | 8 |
immune recognition | 8 |
cold pbs | 8 |
positive cases | 8 |
provide evidence | 8 |
transport medium | 8 |
strain isolated | 8 |
avian viral | 8 |
cov replication | 8 |
reagent kit | 8 |
fold dilutions | 8 |
asfv genotype | 8 |
cell monolayer | 8 |
like particle | 8 |
identify host | 8 |
mut mir | 8 |
secondary infection | 8 |
control serum | 8 |
bat virus | 8 |
interference inhibition | 8 |
rna expression | 8 |
compared using | 8 |
tbk ikk | 8 |
cells via | 8 |
porcine hemagglutinating | 8 |
shock syndrome | 8 |
stem cell | 8 |
neutralizing epitopes | 8 |
increased risk | 8 |
viral transmission | 8 |
infectious cdna | 8 |
first identified | 8 |
membrane glycoprotein | 8 |
antibiotic treatment | 8 |
viral glycoprotein | 8 |
many studies | 8 |
samples positive | 8 |
length infectious | 8 |
mediated membrane | 8 |
wwihs score | 8 |
pol processivity | 8 |
high degree | 8 |
proteome analysis | 8 |
scanning electron | 8 |
erk mapk | 8 |
children less | 8 |
hydrophobic protein | 8 |
relatively low | 8 |
mouse sera | 8 |
south korean | 8 |
natural reservoirs | 8 |
rna samples | 8 |
days later | 8 |
targeting dna | 8 |
bigdye terminator | 8 |
pcr buffer | 8 |
laboratory work | 8 |
type dna | 8 |
published article | 8 |
virus molecular | 8 |
bronchitis coronavirus | 8 |
infection control | 8 |
viral inhibition | 8 |
leukosis virus | 8 |
recombinant plasmid | 8 |
one cycle | 8 |
ii viral | 8 |
infection experiments | 8 |
transcription pcr | 8 |
encephalitis viruses | 8 |
dengue shock | 8 |
membrane proteins | 8 |
molecular analysis | 8 |
clart hpv | 8 |
viruses causing | 8 |
asian cpv | 8 |
results show | 8 |
considered positive | 8 |
clinical outcomes | 8 |
incubation period | 8 |
hmpv filaments | 8 |
also included | 8 |
animal species | 8 |
annealing temperature | 8 |
rna quasispecies | 8 |
purified recombinant | 8 |
human gut | 8 |
gold particles | 8 |
southern china | 8 |
showed better | 8 |
natural host | 8 |
another study | 8 |
pcr results | 8 |
dietary zn | 8 |
glycoprotein precursor | 8 |
pierce biotechnology | 8 |
severe neurological | 8 |
luciferase gene | 8 |
distilled water | 8 |
pcr positive | 8 |
secondary bacterial | 8 |
largely unknown | 8 |
ibv beaudette | 8 |
clinical management | 8 |
clinical trials | 8 |
cleavage sites | 8 |
relative expression | 8 |
target mirnas | 8 |
virus attachment | 8 |
two species | 8 |
contained infectious | 8 |
vir virus | 8 |
using clustal | 8 |
novel method | 8 |
npa samples | 8 |
per sample | 8 |
logistic regression | 8 |
remains unknown | 8 |
liquid chromatography | 8 |
zoonotic potential | 8 |
effective vaccines | 8 |
henipavirus envelope | 8 |
comparative sequence | 8 |
streaked dwarf | 8 |
ubc actin | 8 |
point mutation | 8 |
per reaction | 8 |
sri lanka | 8 |
molecular clock | 8 |
using parsimony | 8 |
dnase treatment | 8 |
simplified vidisca | 8 |
quantitative analysis | 8 |
using standard | 8 |
nc mimics | 8 |
log increase | 8 |
critical role | 8 |
acid identities | 8 |
rn test | 8 |
fluorescein isothiocyanate | 8 |
cell receptors | 8 |
promoter region | 8 |
pig farms | 8 |
binding site | 8 |
cell debris | 8 |
bars represent | 8 |
dependent enhancement | 8 |
established fq | 8 |
bootstrap replicates | 8 |
new virus | 8 |
increased expression | 8 |
infection prevention | 8 |
cytokine production | 8 |
epitope se | 8 |
virus propagation | 8 |
wild felids | 8 |
loaded onto | 8 |
immunofluorescence staining | 8 |
medium containing | 8 |
base pairs | 8 |
gene regions | 8 |
suckling piglets | 8 |
reaction buffer | 8 |
viral genes | 8 |
three years | 8 |
spitc derivatization | 8 |
kg day | 8 |
borne encephalitis | 8 |
dmem containing | 8 |
substitution model | 8 |
ribosomal rna | 8 |
future studies | 8 |
hadv detection | 8 |
tumour necrosis | 8 |
stranded positive | 8 |
viral quasispecies | 8 |
dmem medium | 8 |
green fluorescence | 8 |
defence mechanisms | 8 |
protein showed | 8 |
pr virus | 8 |
using trizol | 8 |
first detected | 8 |
hcvpp infection | 8 |
linear regression | 8 |
recombinant hmpv | 8 |
laboratory diagnosis | 8 |
cell apoptosis | 8 |
time consuming | 8 |
mbl gene | 8 |
mutation pressure | 8 |
gp superfamily | 8 |
embryonic death | 8 |
virus recovery | 8 |
harbouring endogenous | 8 |
pcr inhibition | 8 |
viral genomes | 8 |
selective pressure | 8 |
receptor function | 8 |
slightly higher | 8 |
rnai screening | 8 |
normal control | 8 |
deleted virus | 8 |
clinical trial | 8 |
including human | 8 |
virus panel | 8 |
capture elisa | 8 |
data indicate | 8 |
laboratory procedures | 8 |
using rna | 8 |
infected llc | 8 |
serum sample | 8 |
human pathogens | 8 |
transcriptional activity | 8 |
virus positive | 8 |
virus filaments | 8 |
spike proteins | 8 |
fold serial | 8 |
genetic recombination | 8 |
assay using | 8 |
hmpv proteins | 8 |
secondary dhf | 8 |
watery diarrhea | 8 |
source water | 8 |
viral capsid | 8 |
pdm influenza | 8 |
peritoneal macrophages | 8 |
baculovirus gp | 8 |
group showed | 8 |
human infections | 8 |
proteolytic cleavage | 8 |
synthetic peptide | 8 |
embryonic kidney | 8 |
electron microscope | 8 |
hcv envelope | 8 |
fapn expression | 8 |
hydrophobicity scale | 8 |
study indicated | 8 |
sera samples | 8 |
million people | 8 |
confocal microscope | 8 |
virus species | 8 |
ct strain | 8 |
respiratory failure | 8 |
virus serotypes | 8 |
infection human | 8 |
fields virology | 7 |
protein plays | 7 |
taqman probe | 7 |
mean fluorescence | 7 |
virus cell | 7 |
based enzyme | 7 |
using maximum | 7 |
clinical course | 7 |
years ago | 7 |
colony formation | 7 |
fluorescent microscope | 7 |
virus dna | 7 |
cause disease | 7 |
also important | 7 |
cellular receptor | 7 |
democratic republic | 7 |
infected crfk | 7 |
lp cells | 7 |
infected cultures | 7 |
mainland china | 7 |
short hairpin | 7 |
done using | 7 |
viruses present | 7 |
monitored daily | 7 |
quality control | 7 |
virus expressing | 7 |
thermo scientific | 7 |
higher sensitivity | 7 |
sirna expression | 7 |
spent media | 7 |
infect humans | 7 |
viral lysis | 7 |
cell populations | 7 |
urgent need | 7 |
different stages | 7 |
respiratory secretions | 7 |
cerebrospinal fluid | 7 |
avian diseases | 7 |
species tropism | 7 |
two main | 7 |
laboratory personnel | 7 |
potential use | 7 |
previous page | 7 |
probably due | 7 |
cytometric analysis | 7 |
cervical swabs | 7 |
approximately kb | 7 |
enterovirus species | 7 |
virus genotypes | 7 |
study using | 7 |
different mechanisms | 7 |
using specific | 7 |
dpi strain | 7 |
coronaviridae family | 7 |
linked glycosylation | 7 |
without pa | 7 |
central role | 7 |
hcv genotype | 7 |
pcr purification | 7 |
primary dhf | 7 |
virus antigen | 7 |
total viral | 7 |
contributed equally | 7 |
seropositive rates | 7 |
live virus | 7 |
rayon throat | 7 |
based detection | 7 |
spike igg | 7 |
national natural | 7 |
intestinal tract | 7 |
protein induces | 7 |
virus taxonomy | 7 |
resistant influenza | 7 |
poorly understood | 7 |
human embryonic | 7 |
human stool | 7 |
control plasmid | 7 |
accessory protein | 7 |
asf outbreaks | 7 |
chicken flocks | 7 |
flavivirus genus | 7 |
induces apoptosis | 7 |
three days | 7 |
critically revised | 7 |
complementary dna | 7 |
infected tissues | 7 |
vp region | 7 |
phase i | 7 |
i viral | 7 |
various viruses | 7 |
limited number | 7 |
commercial test | 7 |
fat milk | 7 |
infectious clone | 7 |
human herpes | 7 |
specific pcr | 7 |
infect cells | 7 |
ml spiked | 7 |
three new | 7 |
pcr protocol | 7 |
spring source | 7 |
fold diluted | 7 |
convalescent plasma | 7 |
rapid identification | 7 |
basic amino | 7 |
order mononegavirales | 7 |
virus subgroup | 7 |
protection study | 7 |
flow cytometer | 7 |
direct contact | 7 |
genus flavivirus | 7 |
clinical disease | 7 |
species identification | 7 |
natural reservoir | 7 |
tata box | 7 |
may result | 7 |
candidate vaccine | 7 |
pcr inhibitors | 7 |
hospitalized patients | 7 |
hemagglutinin gene | 7 |
earlier studies | 7 |
valley fever | 7 |
epidemiological data | 7 |
human cd | 7 |
viral membrane | 7 |
triplicate samples | 7 |
vivo studies | 7 |
virus characterization | 7 |
rna viral | 7 |
rna transcribed | 7 |
estimating fifty | 7 |
attenuated porcine | 7 |
genomic regions | 7 |
per year | 7 |
virus spread | 7 |
rtpcr detected | 7 |
recombinant viruses | 7 |
distinct mechanisms | 7 |
virus evolution | 7 |
inflammatory responses | 7 |
cell population | 7 |
nuclear factor | 7 |
institutional review | 7 |
overlapping genes | 7 |
rna shedding | 7 |
year old | 7 |
dengue serotype | 7 |
coronary artery | 7 |
also affect | 7 |
genetics system | 7 |
infect dis | 7 |
neonatal herpes | 7 |
taqman real | 7 |
west africa | 7 |
expression profiles | 7 |
igg antibodies | 7 |
infection rates | 7 |
may prove | 7 |
coding sequences | 7 |
null control | 7 |
cotton cloth | 7 |
primer sets | 7 |